Interní Med. 2007; 9(12): 544-547

Irritable bowel syndrom

prof. MUDr. Milan Lukáš CSc
IV. interní klinika VFN a 1. LF UK, Praha

The funtional bowel disorders and especialy irritable bowel syndrome and functional large bowel dyspepsia are the final diagnosis in many of our patients. The irritable bowel syndrome is characterised by changes of bowel habits with abdominal dyscomfort or abdominal pain. The pathophysiology of irritable bowel syndrome is still not completely understood, but many factors are considered: a) abnormal motility pattern includes of the pathologic gastro-colic reflex; b) postinfective consequences in the large bowel mucosa; c) visceral hyperalgesia and increased perception of physiological or minor noxious stimuli; d) abnormal intestinal secretion with accumulation of fluid in the intestinal lumen. Regarding on predominant symptoms we can divided irritable bowel syndrome into three clinical groups: a) diarrheal type; b) contipated type c) mixed typ. Diagnosis of the disease is based on the typical clinical picture and absent of alarming symptoms. In younger patients is not necessary to perform some invasive investigation. In all patients with alarming symptoms colonoscopy is absolute indicated. Therapy of irritable bowel syndrome has to be complex and symptomatic. Dietary and life style arrangement are self-evidents. The drugs therapy include antidiarrheal agents (diphenyloxylate, loperamide, cholestyramine), bulking and salinic laxatives, tricyclic antidepressants and neuroleptics, musculotropic antispasmodics and at the future agonists of 5HT4 receptors.

Keywords: bowel dyspepsia, constipation, diarrhea, abdominal pain

Published: January 20, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lukáš M. Irritable bowel syndrom. Interní Med. 2007;9(12):544-547.
Download citation

References

  1. Bortlík M. Spasmolytika v gastroenterologii. Remedia, 2002; 12 (1): 41-49.
  2. Colins SM, Ismail M. Irritable bowel syndrome. Evidence-Based Gastroenterology. Edited by: E. Jan Irvine and Richard H. Hunt BC Decker Inc, Hamilton, London 2001.
  3. Drossman DA, Corazzuiany E, Halley MJ, et: Rome II: a multifactorial consensus document on functional gastrointestinal diaseases. Gut, 1999; 45: 43-47. Go to original source... Go to PubMed...
  4. Howship J. Practical remarks on the discrimination and successful treatment of the spasmodic stricture of the colon. London: Burgess and Hill, 1830.
  5. Chaudhary NA, Truelove SC. The irritable colon syndrome. Q J Med 1962; 31: 307-322.
  6. Longstreth GF, Thompson WG, Chey W, et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491. Go to original source... Go to PubMed...
  7. Lukáš M. Muskulotropní spasmolytika a spasmoanalgetika. In. Remedia compendium. Třetí vydání. Panax 1999.
  8. Powel R. On certain painfull afflications of the intestinal canal. Med Trans Coll Phys 1818; 6: 106-117. Go to original source...
  9. Poynard T, Regimbeau C, Benhamou Y. Metanalysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001; 15: 355-361. Go to original source... Go to PubMed...
  10. Spiller, RO. Postinfectious irritable syndrome. Gastroenterology 2003; 124: 1662-1671. Go to original source... Go to PubMed...
  11. Thompson WG, Dotewall G, Drossman, DA, et al. Irritable bowel syndrome: Guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92-95.
  12. Thompson WG, Creed FH, Drossman DA. Functional bowel disorders and functional abdominal pain. Gastroenterol Int 1992; 5: 75-91.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.